Therakos
From Wikipedia, the free encyclopedia
Therakos, Inc. was established in 1981 as a research project within Johnson & Johnson, it became a separate entity in 1987. It is located in Exton, PA.
Its primary product is a cellular therapy which involves the treatment of cutaneous T cell lymphoma (CTCL) with photopheresis and a drug, it has been approved by the United States FDA.